恩格列净治疗射血分数降低型心力衰竭的成本-效果分析
Cost-effectiveness analysis harmacoeconomic evaluation of empagliflozin in the treatment of heart failure with reduced ejection fraction
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 | 〉 |